1. 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine. (31st December 2020) Authors: Brar, Indira; Ruane, Peter; Ward, Douglas; Molina, Jean-michel; Mills, Anthony; Berhe, Mezgebe; Brinson, Cynthia; Rampogal, Moti; Benson, Paul; Henry, Keith; Huang, Hailin; Andreatta, Kristen; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 626. The Efficacy and Safety of Maintenance with Doravirine Plus Two NRTIs after Initial Suppression in Adults with HIV-1 in the DRIVE-FORWARD Clinical Trial: Results from the Study Extension through 192 Weeks. (4th December 2021) Authors: Cahn, Pedro; Molina, Jean-michel; Lombaard, Johan; Squires, Kathleen; Kumar, Sushma; Wan, Hong; Teal, Valerie; Asante-Appiah, Ernest; Sklar, Peter; Martin, Elizabeth A; Lahoulou, Rima Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗